Complete Filing Data
Advanced Flower Capital Inc. reported Stockholders Equity of $175.57 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Advanced Flower Capital Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net Income * | -$20.7M | $16.8M | $21.0M | $35.9M | $21.0M |
| Operating Expenses | $15.7M | $17.3M | $21.6M | $23.4M | $14.4M |
| Income Tax Expense Benefit | -$613.4K | $447.6K | $1.7M | $1.0M | $35.2K |
| General And Administrative Expense | $3.2M | $4.0M | $5.0M | $4.7M | $3.2M |
| Revenue From Contract With Customer Excluding Assessed Tax | $24.6M | $45.7M | $63.9M | $74.7M | |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$21.3M | $14.3M | $22.4M | $37.0M | $21.0M |
| Income Taxes Paid Net | $211.1K | $1.3M | $1.7M | $952.5K | $35.2K |
| Income Loss From Continuing Operations Per Diluted Share | -$0.95 | $0.64 | $1.01 | ||
| Income Loss From Continuing Operations Per Basic Share | -$0.95 | $0.64 | $1.01 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$12.5M | -$13.2M | $4.1M | $1.4M | $16.4M | -$54.1K | $8.0M | $12.1M | $10.0M | $11.5M | $11.4M | $10.2M | $7.9M | $4.6M | $1.4M | $2.1M |
| Operating Expenses | $2.8M | $2.6M | $2.5M | $2.5M | $5.8M | $5.5M | $5.2M | $4.9M | $6.4M | $5.3M | $5.8M | $6.4M | $3.8M | $3.0M | $3.1M | $1.1M |
| Income Tax Expense Benefit | -$874.7K | -$138.0K | $112.4K | $386.3K | $286.0K | $158.4K | $663.2K | $167.6K | $175.1K | $167.2K | $164.3K | $18.3K | $0.00 | $0.00 | $0.00 | $0.00 |
| General And Administrative Expense | $674.3K | $845.8K | $735.0K | $857.3K | $1.0M | $1.1M | $986.8K | $1.1M | $2.0M | $1.1M | $1.2M | $1.1M | $858.7K | $706.9K | $462.5K | $204.3K |
| Revenue From Contract With Customer Excluding Assessed Tax | $6.5M | $6.2M | $6.6M | $8.9M | $16.4M | $12.7M | $15.3M | $16.1M | $16.8M | $18.1M | $19.9M | $16.9M | $10.6M | $8.7M | $4.7M | $1.6M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$13.4M | -$13.3M | $4.2M | $1.6M | $15.5M | -$1.4M | $8.6M | $12.3M | $10.2M | $11.6M | $11.5M | $10.2M | $7.9M | $4.6M | $1.4M | $2.1M |
| Income Taxes Paid Net | $138.00 | $124.7K | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||
| Income Loss From Continuing Operations Per Diluted Share | -$0.57 | -$0.60 | $0.18 | $0.05 | $0.74 | -$0.08 | $0.39 | |||||||||
| Income Loss From Continuing Operations Per Basic Share | -$0.57 | -$0.60 | $0.18 | $0.05 | $0.74 | -$0.08 | $0.39 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Stockholders Equity | $175.6M | $201.4M | $320.1M | $339.1M | $273.1M | $91.6M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $38.6M | $103.6M | $121.6M | $140.4M | $109.2M | $9.6M |
| Unrealized Gain Loss On Investments | -$7.9M | -$9.8M | -$8.5M | -$3.6M | $619.8K | |
| Dividends Common Stock Cash | $12.0M | $37.5M | $40.9M | $44.8M | $22.6M | |
| Accrued Exchange Fee Rebate | $854.4K | $948.0K | $1.7M | $1.8M | $1.8M | |
| Loans Receivable Fair Value Disclosure | $26.1M | $30.5M | $61.7M | $99.2M | $77.1M | $48.6M |
| Retained Earnings Accumulated Deficit | -$83.4M | -$50.7M | -$30.0M | -$10.0M | -$1.1M | $517.7K |
| Prepaid Expense And Other Assets | $2.4M | $1.2M | $688.4K | $460.8K | $949.3K | $72.1K |
| Preferred Stock Value | $0.00 | $0.00 | $1.00 | $1.00 | $1.00 | $1.00 |
| Management Fee Payable | $716.2K | $1.9M | $3.5M | $3.9M | $2.8M | $222.1K |
| Liabilities And Stockholders Equity | $275.6M | $402.1M | $466.6M | $519.2M | $464.8M | $94.0M |
| Liabilities | $100.0M | $200.7M | $146.5M | $180.1M | $191.8M | $2.3M |
| Interest Receivable | $899.4K | $2.0M | $3.7M | $5.3M | $4.4M | $927.3K |
| Financing Receivable Covered Allowance For Credit Loss | $76.5K | $166.7K | $115.5K | $754.1K | $683.2K | $60.5K |
| Financing Receivable Allowance For Credit Losses | $46.1M | $30.4M | $26.3M | $13.5M | $2.4M | $404.9K |
| Dividends Payable Current And Noncurrent | $0.00 | $7.4M | $9.8M | $11.4M | $8.2M | $0.00 |
| Common Stock Value | $235.3K | $223.3K | $204.6K | $203.6K | $163.9K | $61.8K |
| Cash And Cash Equivalents At Carrying Value | $38.6M | $103.6M | $90.4M | $140.4M | $109.2M | $9.6M |
| Assets | $275.6M | $402.1M | $466.6M | $519.2M | $464.8M | $94.0M |
| Accrued Direct Administrative Expenses | $374.9K | $1.2M | $1.5M | $1.8M | $1.3M | $550.7K |
| Accretion Amortization Of Discounts And Premiums Investments | $3.5M | $8.0M | $6.1M | $11.8M | $5.6M | |
| Accounts Payable And Other Accrued Liabilities | $773.6K | $501.3K | $704.7K | $836.6K | ||
| Dividends Preferred Stock Cash | $7.5K | $15.0K | $15.0K | $15.0K | ||
| Notes Receivable Gross | $0.00 | $1.9M | $2.0M | $2.2M | $2.5M | $3.3M |
| Interest Payable Current And Noncurrent | $763.2K | $894.6K | $894.0K | $1.0M | $991.8K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $169.3M | $184.7M | $200.8M | $206.1M | $314.3M | $310.6M | $338.8M | $340.3M | $337.9M | $347.4M | $338.2M | $336.5M | $274.4M | $268.5M | $216.3M | $80.9M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $45.1M | $3.4M | $3.3M | $122.2M | $170.3M | $82.3M | $73.2M | $82.1M | $80.6M | $36.3M | $45.6M | $63.6M | $70.0M | $124.6M | $126.8M | $31.2M | ||
| Unrealized Gain Loss On Investments | -$9.7M | -$1.1M | -$685.5K | -$4.6M | -$1.4M | -$3.6M | $787.8K | -$462.9K | -$1.5M | -$637.3K | -$1.0M | $80.8K | $1.4M | -$483.2K | -$144.4K | $1.6M | ||
| Dividends Common Stock Cash | $3.4M | $3.4M | $5.2M | $7.2M | $13.0M | $9.9M | $9.8M | $9.8M | $11.5M | $11.4M | $11.1M | $10.9M | $7.1M | $5.1M | $2.2M | |||
| Accrued Exchange Fee Rebate | $235.7K | $260.7K | $128.6K | $180.6K | $214.2K | $374.8K | $405.3K | $427.6K | $478.6K | $432.4K | $488.1K | $387.5K | $257.0K | $182.7K | $237.7K | $84.2K | ||
| Loans Receivable Fair Value Disclosure | $16.9M | $26.8M | $28.6M | $31.4M | $34.7M | $55.0M | $70.0M | $95.9M | $99.9M | $94.1M | $95.2M | $95.1M | $76.3M | $44.9M | $50.3M | |||
| Retained Earnings Accumulated Deficit | -$84.3M | -$68.4M | -$51.8M | -$42.4M | -$36.5M | -$39.9M | -$10.9M | -$9.1M | -$11.4M | -$1.5M | -$1.6M | -$1.8M | $94.8K | -$765.5K | -$306.4K | |||
| Prepaid Expense And Other Assets | $2.3M | $1.6M | $11.3M | $423.0K | $691.8K | $532.8K | $526.2K | $697.9K | $420.2K | $564.0K | $620.0K | $604.2K | $391.2K | $189.0K | $1.1M | |||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.00 | $1.00 | $1.00 | $1.00 | $1.00 | $1.00 | $1.00 | $1.00 | $1.00 | $1.00 | |||
| Management Fee Payable | $715.1K | $680.4K | $816.2K | $981.8K | $4.0M | $3.5M | $3.6M | $3.3M | $3.7M | $3.8M | $4.2M | $3.8M | $2.5M | $2.1M | $876.7K | |||
| Liabilities And Stockholders Equity | $288.7M | $290.6M | $321.7M | $366.6M | $458.0M | $476.4M | $445.1M | $454.0M | $447.8M | $471.3M | $459.3M | $454.1M | $303.9M | $278.5M | $221.5M | |||
| Liabilities | $119.4M | $105.9M | $120.9M | $160.6M | $143.7M | $165.8M | $106.3M | $113.7M | $110.0M | $123.9M | $121.1M | $117.6M | $29.5M | $10.1M | $5.2M | |||
| Interest Receivable | $781.2K | $1.6M | $1.8M | $1.5M | $1.7M | $4.4M | $4.6M | $2.6M | $3.9M | $4.4M | $4.8M | $4.2M | $2.4M | $1.2M | $1.2M | |||
| Financing Receivable Covered Allowance For Credit Loss | $163.9K | $127.1K | $142.7K | $164.7K | $157.3K | $9.1K | $166.8K | $259.2K | $585.8K | $688.7K | $594.8K | $629.2K | $692.3K | $476.1K | $283.2K | |||
| Financing Receivable Allowance For Credit Losses | $51.2M | $43.8M | $29.7M | $25.1M | $25.0M | $31.3M | $14.3M | $13.1M | $14.4M | $5.5M | $5.0M | $3.4M | $1.1M | $701.1K | $248.3K | |||
| Dividends Payable Current And Noncurrent | $3.4M | $3.4M | $5.2M | $7.2M | $13.0M | $9.9M | $9.8M | $9.8M | $11.5M | $11.4M | $11.1M | $10.9M | $0.00 | $0.00 | ||||
| Common Stock Value | $225.9K | $226.0K | $226.0K | $218.8K | $206.7K | $206.7K | $204.6K | $204.6K | $204.9K | $203.6K | $197.9K | $196.8K | $163.9K | $161.2K | $133.7K | |||
| Cash And Cash Equivalents At Carrying Value | $45.1M | $3.4M | $3.3M | $122.2M | $170.3M | $82.3M | $73.2M | $82.1M | $80.6M | $36.3M | $45.6M | $63.6M | $70.0M | $124.6M | $126.8M | |||
| Assets | $288.7M | $290.6M | $321.7M | $366.6M | $458.0M | $476.4M | $445.1M | $454.0M | $447.8M | $471.3M | $459.3M | $454.1M | $303.9M | $278.5M | $221.5M | |||
| Accrued Direct Administrative Expenses | $733.9K | $677.0K | $568.5K | $878.4K | $884.3K | $962.7K | $1.3M | $1.2M | $1.1M | $1.4M | $1.2M | $906.7K | $846.7K | $530.9K | $365.6K | |||
| Accretion Amortization Of Discounts And Premiums Investments | $873.8K | $1.9M | $1.2M | $4.0M | $707.8K | $173.1K | ||||||||||||
| Accounts Payable And Other Accrued Liabilities | $1.1M | $736.2K | $820.7K | $658.2K | $1.4M | $1.0M | $821.6K | $1.3M | $1.6M | $1.1M | $986.7K | $1.6M | $1.5M | $520.6K | $1.4M | $404.9K | $154.9K | |
| Dividends Preferred Stock Cash | $7.5K | $7.5K | $7.5K | $0.00 | $7.5K | |||||||||||||
| Notes Receivable Gross | $0.00 | $0.00 | $1.9M | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M | $2.2M | $2.2M | $2.2M | |||||||
| Interest Payable Current And Noncurrent | $2.2M | $941.2K | $2.3M | $2.2M | $888.8K | $2.2M | $2.2M | $889.2K | $2.2M | $2.4M | $958.3K | $2.4M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Share-Based Compensation * | $6.8M | $1.4M | $988.9K | $1.3M | $1.7M |
| Financing Cash Flow * | -$111.1M | -$34.7M | -$68.5M | $16.1M | $338.5M |
| Investing Cash Flow * | $34.9M | -$4.8M | $28.5M | -$16.3M | -$248.5M |
| Operating Cash Flow * | $11.2M | $21.6M | $21.2M | $31.3M | $9.5M |
| Proceeds From Principal Repayments On Loans And Leases Held For Investment | $80.4M | $58.8M | $59.0M | $120.0M | $22.4M |
| Payments To Acquire Loans Held For Investment | $45.5M | $112.5M | $51.8M | $162.9M | $272.6M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $1.2M | $634.7K | $346.8K | -$859.2K | $877.2K |
| Increase Decrease In Other Operating Liabilities | -$822.7K | -$288.7K | -$357.4K | $519.2K | $773.8K |
| Increase Decrease In Other Employee Related Liabilities | -$1.2M | -$1.5M | -$420.0K | $1.1M | $2.6M |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $265.5K | -$213.0K | -$133.7K | -$674.2K | $1.2M |
| Increase Decrease In Accrued Interest Receivable Net | -$1.1M | -$1.7M | -$1.5M | $844.5K | $3.5M |
| Proceeds From Sale Of Loans Held For Investment | $0.00 | $96.1M | $21.3M | $10.6M | $15.5M |
| Proceeds From Issuance Of Common Stock | $0.00 | $15.8M | $0.00 | $75.1M | $185.5M |
| Payments Of Financing Costs | $280.4K | $275.6K | $225.0K | $578.5K | $3.5M |
| Increase Decrease In Interest Reserve | $0.00 | $4.7M | $2.0M | $6.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share-Based Compensation * | $487.4K | $484.5K | $553.7K | $218.6K | $369.3K | $543.2K | $294.0K | $130.8K | $268.7K | $114.1K | $117.4K | $990.0K | $51.4K | $11.5K | $1.6M | $0.00 | |
| Financing Cash Flow * | -$85.1M | $8.2M | -$79.1M | -$20.2M | $121.7M | $31.9M | |||||||||||
| Investing Cash Flow * | -$19.1M | -$53.9M | $15.0M | -$30.0M | -$6.9M | -$642.7K | |||||||||||
| Operating Cash Flow * | $3.9M | $6.4M | $4.4M | $4.7M | $2.4M | -$56.4K | |||||||||||
| Proceeds From Principal Repayments On Loans And Leases Held For Investment | $6.5M | $26.1M | $1.3M | $2.8M | $20.4M | $107.7K | $137.3K | ||||||||||
| Payments To Acquire Loans Held For Investment | $15.5M | $35.3M | $1.5M | $50.5M | $7.1M | $780.0K | |||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $98.7K | -$50.9K | -$1.4K | -$373.8K | -$68.0K | $25.0K | |||||||||||
| Increase Decrease In Other Operating Liabilities | -$629.0K | -$523.5K | -$757.6K | -$417.7K | -$185.1K | $202.5K | |||||||||||
| Increase Decrease In Other Employee Related Liabilities | -$1.1M | -$9.0K | -$187.5K | $1.0M | $654.5K | $142.1K | |||||||||||
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $312.6K | $125.8K | $776.5K | $110.0K | $250.0K | $118.0K | |||||||||||
| Increase Decrease In Accrued Interest Receivable Net | -$166.8K | -$198.5K | -$1.4M | -$177.7K | $278.0K | $783.7K | |||||||||||
| Proceeds From Sale Of Loans Held For Investment | $0.00 | $1.8M | $13.7M | $0.00 | $0.00 | ||||||||||||
| Proceeds From Issuance Of Common Stock | $0.00 | $63.9M | $127.0M | $31.9M | |||||||||||||
| Payments Of Financing Costs | $16.0K | $0.00 | $0.00 | $966.8K | $3.1M | $0.00 | |||||||||||
| Increase Decrease In Interest Reserve | $0.00 | $3.0M | $4.2M | $82.3K | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 22.2M | 20.8M | 20.3M | 19.8M | 13.4M | |
| Earnings Per Share Basic | $-0.95 | $0.78 | $1.02 | $1.80 | $1.57 | |
| Weighted Average Number Of Diluted Shares Outstanding | 22.3M | 20.9M | 20.3M | 20.0M | 13.8M | |
| Earnings Per Share Diluted | $-0.95 | $0.78 | $1.02 | $1.79 | $1.52 | |
| Common Stock Dividends Per Share Cash Paid | $0.53 | $1.77 | $2.00 | $2.23 | $1.67 | |
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 |
| Common Stock Shares Authorized | 50.0M | 50.0M | 50.0M | 50.0M | 25.0M | 15.0M |
| Preferred Stock Shares Authorized | 10.0K | 10.0K | 10.0K | 10.0K | 10.0K | 10.0K |
| Preferred Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 |
| Common Stock Shares Outstanding | 23.5M | 22.3M | 20.5M | 20.4M | 16.4M | 6.2M |
| Common Stock Shares Issued | 23.5M | 22.3M | 20.5M | 20.4M | 16.4M | 6.2M |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 125.00 | 125.00 | 125.00 | 125.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 125.00 | 125.00 | 125.00 | 125.00 |
| Preferred Stock Dividends Per Share Cash Paid | $60.00 | $120.00 | $120.00 | $120.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 22.1M | 22.1M | 22.1M | 20.7M | 20.4M | 20.4M | 20.3M | 20.3M | 20.3M | 20.0M | 19.7M | 19.3M | 16.4M | 13.5M | 7.1M | 5.4M |
| Earnings Per Share Basic | $-0.57 | $-0.60 | $0.18 | $0.06 | $0.80 | $-0.01 | $0.39 | $0.59 | $0.49 | $0.57 | $0.57 | $0.53 | $0.48 | $0.34 | $0.20 | $0.39 |
| Weighted Average Number Of Diluted Shares Outstanding | 22.2M | 22.1M | 22.1M | 20.8M | 20.4M | 20.4M | 20.3M | 20.3M | 20.5M | 20.1M | 19.8M | 19.6M | 16.8M | 13.8M | 7.5M | 5.4M |
| Earnings Per Share Diluted | $-0.57 | $-0.60 | $0.18 | $0.06 | $0.80 | $-0.01 | $0.39 | $0.59 | $0.49 | $0.57 | $0.57 | $0.52 | $0.47 | $0.34 | $0.19 | $0.39 |
| Common Stock Dividends Per Share Cash Paid | $0.15 | $0.15 | $0.23 | $0.33 | $0.63 | $0.48 | $0.48 | $0.48 | $0.56 | $0.56 | $0.56 | $0.55 | $0.43 | $0.38 | $0.36 | |
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | ||
| Common Stock Shares Authorized | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 25.0M | 25.0M | 25.0M | |
| Preferred Stock Shares Authorized | 10.0K | 10.0K | 10.0K | 10.0K | 10.0K | 10.0K | 10.0K | 10.0K | 10.0K | 10.0K | 10.0K | 10.0K | 10.0K | 10.0K | 10.0K | |
| Preferred Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | |
| Common Stock Shares Outstanding | 22.6M | 22.6M | 22.6M | 21.9M | 20.7M | 20.7M | 20.5M | 20.5M | 20.5M | 20.4M | 19.9M | 19.7M | 16.4M | 16.1M | 13.4M | |
| Common Stock Shares Issued | 22.6M | 22.6M | 22.6M | 21.9M | 20.7M | 20.7M | 20.5M | 20.5M | 20.5M | 20.4M | 19.9M | 19.7M | 16.4M | 16.1M | 13.4M | |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 125.00 | 125.00 | 125.00 | 125.00 | 125.00 | 125.00 | 125.00 | 125.00 | 125.00 | 125.00 | |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 125.00 | 125.00 | 125.00 | 125.00 | 125.00 | 125.00 | 125.00 | 125.00 | 125.00 | 125.00 | |
| Preferred Stock Dividends Per Share Cash Paid | $60.00 | $60.00 | $60.00 | $60.00 | $60.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Professional Fees | $1.5M | $1.6M | $1.5M | $1.6M | $1.1M | |
| Labor And Related Expense | $2.9M | $10.4M | $14.1M | $15.8M | $8.3M | |
| Investment Income Interest | $31.3M | $52.0M | $70.3M | $81.5M | $38.1M | |
| Realized Investment Gains Losses | $0.00 | -$93.3K | -$1.3M | $450.0K | $450.0K | |
| Valuation Allowances And Reserves Balance | $0.00 | $3.2M | $4.8M | $1.3M | ||
| Loans Held For Investment Carrying Value | $253.6M | $293.3M | $301.3M | $285.2M | $257.2M | $31.8M |
| Provision For Loan Losses Expensed | $22.6M | $4.2M | $12.1M | $11.2M | $2.6M | |
| Loans Held For Investment Cost | $53.7M | $50.2M | $71.6M | $100.6M | $74.9M | $47.0M |
| Investment Income Investment Expense | $6.8M | $6.3M | $6.4M | $6.8M | ||
| Amortization Of Financing Costs | $876.4K | $1.0M | $950.9K | $921.5K | $135.0K | |
| Additional Paid In Capital | $258.7M | $251.9M | $349.8M | $348.8M | $274.2M | $91.1M |
| Payment In Kind Interest | $464.8K | $3.1M | $10.9M | $8.4M | $4.5M | |
| Interest Paid Net | $6.0M | $5.3M | $5.5M | $5.8M | $0.00 | |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $1.4M | $988.9K | $1.3M | $1.7M | ||
| Stock Issued During Period Value New Issues | $15.6M | $73.3M | $181.5M | |||
| Original Issue Discount Withheld From Funding Of Loans | $1.3M | $6.2M | $7.4M | $7.8M | $15.0M | |
| Interest Reserve Withheld From Funding Of Loan | $0.00 | $1.5M | $450.0K | $9.5M | ||
| Senior Notes | $76.3M | $88.6M | $88.0M | $97.1M | $96.6M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Professional Fees | $354.8K | $361.1K | $371.9K | $417.5K | $367.4K | $447.0K | $295.5K | $419.6K | $420.9K | $324.8K | $293.3K | $399.4K | $396.1K | $194.6K | $135.5K | $89.8K | |
| Labor And Related Expense | $715.1K | $680.4K | $816.2K | $981.8K | $4.0M | $3.5M | $3.6M | $3.3M | $3.7M | $3.8M | $4.2M | $3.8M | $2.5M | $2.1M | $876.7K | $142.1K | |
| Investment Income Interest | $8.2M | $8.1M | $8.5M | $10.5M | $18.0M | $14.3M | $16.8M | $17.7M | $18.5M | $19.8M | $21.7M | $18.6M | $10.6M | $8.7M | $4.7M | $1.6M | |
| Realized Investment Gains Losses | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$93.3K | -$1.2M | $0.00 | -$26.4K | $0.00 | $0.00 | $450.0K | $400.0K | $0.00 | $0.00 | $0.00 | |
| Valuation Allowances And Reserves Balance | $551.0K | $1.1M | $1.7M | $6.1M | $5.2M | $607.2K | $8.3M | $5.5M | $3.2M | $1.4M | $0.00 | ||||||
| Loans Held For Investment Carrying Value | $274.7M | $300.9M | $304.5M | $234.3M | $273.6M | $357.9M | $308.0M | $283.8M | $275.2M | $339.2M | $315.9M | $265.2M | $153.2M | $105.4M | $39.2M | ||
| Provision For Loan Losses Expensed | $7.4M | $15.9M | -$699.4K | $181.4K | -$6.3M | $4.9M | $1.1M | -$1.6M | $702.4K | $542.0K | $1.6M | $905.1K | $660.6K | $645.8K | |||
| Loans Held For Investment Cost | $48.1M | $48.3M | $49.0M | $51.0M | $49.6M | $68.5M | $72.6M | $99.3M | $102.8M | $93.5M | $93.9M | $92.8M | $73.9M | $43.9M | $48.8M | ||
| Investment Income Investment Expense | $1.6M | $1.9M | $1.8M | $1.6M | $1.6M | $1.6M | $1.5M | $1.6M | $1.7M | $1.6M | $1.7M | $1.7M | $0.00 | $0.00 | |||
| Amortization Of Financing Costs | $200.5K | $217.4K | $265.0K | $257.3K | $253.3K | $253.3K | $255.3K | $243.3K | $196.9K | $206.6K | $294.9K | $213.0K | |||||
| Additional Paid In Capital | $253.4M | $252.9M | $252.4M | $248.2M | $350.6M | $350.3M | $349.5M | $349.2M | $349.1M | $348.7M | $339.6M | $338.1M | $274.1M | $269.1M | $216.5M | ||
| Payment In Kind Interest | $118.9K | $1.6M | $4.5M | $1.6M | $559.0K | $79.7K | |||||||||||
| Interest Paid Net | $144.4K | $42.0K | $290.8K | $69.3K | $0.00 | $0.00 | |||||||||||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $218.6K | $369.3K | $543.2K | $294.0K | $130.8K | $268.7K | $114.7K | $117.4K | $990.0K | $51.4K | $11.5K | $1.6M | |||||
| Stock Issued During Period Value New Issues | $12.2M | $9.0M | $1.3M | $63.0M | $5.0M | $52.6M | $123.9M | $78.7M | |||||||||
| Original Issue Discount Withheld From Funding Of Loans | $375.0K | $1.4M | $0.00 | $1.1M | $2.0M | $320.0K | |||||||||||
| Interest Reserve Withheld From Funding Of Loan | $0.00 | $1.5M | $0.00 | $2.0M | $1.4M | ||||||||||||
| Senior Notes | $89.1M | $88.9M | $88.8M | $88.5M | $88.3M | $88.2M | $87.9M | $87.7M | $87.6M | $97.0M | $96.8M | $96.7M |
Most recent annual filing with the SEC: March 4, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.